FDA again bypasses advisers to remove black-box warnings from menopause treatments
The news follows the removal of black-box warnings from six menopause treatments in February, as patients across the US struggle with shortages of the patches.
The FDA did not convene an advisory committee and offered few details on the scientific basis for the decision in the press briefing.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →
Advertisement
Every article behind this summary — 1 article from 1 outlet
Get stories like this in your inbox.
Subscribe — it's freeOne free email at 6am — your topics, deduplicated, five minutes. No account, no paywall.